As of Oct 21
| -1.04 / -1.38%|
The 2 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 82.00, with a high estimate of 83.00 and a low estimate of 81.00. The median estimate represents a +10.10% increase from the last price of 74.48.
The current consensus among 3 polled investment analysts is to Hold stock in Cantel Medical Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.